2022
DOI: 10.3724/abbs.2022006
|View full text |Cite
|
Sign up to set email alerts
|

Functions of non-coding RNAs in regulating cancer drug targets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 165 publications
0
6
0
Order By: Relevance
“…Although our understanding of CRC-related signaling pathways has advanced in recent years, chemotherapy and radiotherapy resistance due to specific molecules in these pathways continues to be a major obstacle to effective treatment ( 4 ). Here’s a possible revision: “Non-coding RNAs (ncRNAs) are known to have significant roles in regulating the chemical and radioresistance of CRC, making them promising targets for the development of new anti-drug and anti-radiation therapy strategies ( 6 , 7 ). These ncRNAs make up the majority (~90%) of the transcribed human genome and include RNAs of varying lengths ( 8 ).…”
Section: Introductionmentioning
confidence: 99%
“…Although our understanding of CRC-related signaling pathways has advanced in recent years, chemotherapy and radiotherapy resistance due to specific molecules in these pathways continues to be a major obstacle to effective treatment ( 4 ). Here’s a possible revision: “Non-coding RNAs (ncRNAs) are known to have significant roles in regulating the chemical and radioresistance of CRC, making them promising targets for the development of new anti-drug and anti-radiation therapy strategies ( 6 , 7 ). These ncRNAs make up the majority (~90%) of the transcribed human genome and include RNAs of varying lengths ( 8 ).…”
Section: Introductionmentioning
confidence: 99%
“… 22 Additionally, lncRNAs are also associated with tumor metabolism, tumor microenvironment, and drug resistance, 23 consequently recognized as potential cancer drug targets. 24 , 25 …”
Section: Introductionmentioning
confidence: 99%
“…22 Additionally, ln-cRNAs are also associated with tumor metabolism, tumor microenvironment, and drug resistance, 23 consequently recognized as potential cancer drug targets. 24,25 Programmed cell death is an essential physiological and pathological process to remove superfluous or damaged cells to ensure healthy development and tissue homeostasis, 26 including apoptosis, autophagy, pyroptosis, ferroptosis, and necroptosis. [27][28][29] Recently, a novel cell death pathway was reported by Tsvetkov et al 30 Cuproptosis is defined as the copper-dependent death of the cells, where the copper binds directly to the lipoylated components of the tricarboxylic acid (TCA) cycle.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, various computational models have been developed to detect possible CircRNA-Disease Associations (CDAs). For example, network embedding and subspace learning method (Xiao et al (2021)), knowledge attention network (Lan et al (2022)), multi-source feature fusion-based machine learning framework (Wang L. et al (2022)), and robust nonnegative matrix factorization model (Peng et al (2022c)) are widely used in CDA prediction.…”
mentioning
confidence: 99%
“…Particularly, noncoding RNAs have dense linkages with human diseases including cancers. Now, RNAs have been diagnostic or prognostic markers of complex diseases ( Hui et al (2011) ; Xu et al (2022) ; Peng et al (2022a) ; Shen et al (2022) ; Zhang T. et al (2022) ; Chai et al (2022) ). In this topic, we aim to analyze diverse RNA data to provide clues for the diagnosis and therapy of various diseases ( Dal Molin et al (2022) ; Wang S. et al (2022) ; Li J. et al (2019) ; Liu et al (2020) ).…”
mentioning
confidence: 99%